Cardiac magnetic resonance characteristics of pediatric Cardiac Teratoma
© Tipton et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
5 day old term female with prenatal history of an intracardiac tumor followed by a post-natal echocardiography indentifying a large cystic mass compressing both ventricles, but without significant outflow tract obstruction. Cardiac MRI imaging showed a very large ventricular septal cystic mass most consistent with a primary cardiac teratoma causing mild LVOT obstruction.
CMR is an established method for evaluation of cardiac masses. It is superior to other modalities as it can provide tissue characteristics, thus allowing highly accurate differentiation of benign from malignant tumors, as well as local mass effects such as outflow compression.
Using Cardiac MRI for assessment of etiology of a massive, septal tumor as well as its effect on LVOT flow and LV filling.
A 5 day old full term female with a prenatal diagnosis of a large intracardiac tumor underwent post-natal echocardiography. Echo confirmed the suspected diagnosis as a large cystic mass compressing both ventricles without significant outflow tract obstruction. Cardiac MRI was performed specifically for further morphologic characterization. Imaging was performed using non-breatheld technique with multiple signal averages while under general endotracheal anesthesia on a 1.5 Tesla GE Excite magnet utilizing an 8-channel phased-array cardiac coil. The CMR sequences included SSFP 2, 3, and 4 chamber views and short axis multislice cine stacks; tagged SPAMM cines in 3 short and 2 long axis planes; gadolinium-enhanced myocardial first pass perfusion and delayed enhancement imaging in both short and long axis planes. Pre- and post-contrast T1 FSE single phase short axis stacks. Both right and left ventricular volumes and tumor volume were measured at end systole and end-diastole using MEDIS QMass software.
CMR provided exquisite anatomic localization and tissue characterization of this pediatric cardiac tumor. It also delineated the extent of viable function within the heart chambers allowing for proper patient management. Based on the MR imaging, no interaction was undertaken. At the time of the last evaluation at 4 months of age, the patient was doing well and was without symptoms. The tumor size was unchanged and the cardiac function remains normal.
There are no financial disclosures.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.